• On 4 August 2026, Rubrik expanded its Agent Cloud platform with Rubrik Agent Identity, an AI-based solution that governs AI agents’ access and permissions in real time, while also deepening its role in the CSAI Foundation’s efforts to secure autonomous AI systems.
• This launch positions Rubrik at the center of “agentic cyber resilience,” aiming to control, monitor, and even rewind AI agents’ actions across existing enterprise identity platforms like Okta and Microsoft Entra ID.
• Next, we’ll explore how Rubrik’s just-in-time AI agent identity controls could influence its investment narrative around AI-driven cyber resilience.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

Rubrik Investment Narrative Recap

To own Rubrik, you need to believe in its pitch as a core cyber resilience and AI security platform, even while it remains loss making with negative equity and a rich sales multiple. The new Rubrik Agent Identity launch directly supports the AI cyber resilience catalyst, but does not clearly change the biggest near term risk: whether early stage AI and identity products can gain enough adoption to justify continued heavy spend and the current valuation.

The most relevant recent announcement here is Rubrik’s role as Lead Founding Partner in the CSAI Foundation’s AI Resilience Center of Excellence, now joined by Qualys and Zscaler as Vanguard members. This broader coalition reinforces Rubrik’s attempt to anchor itself in securing autonomous AI systems, which ties closely to Agent Identity and could influence how investors weigh the AI driven cyber resilience catalyst against competitive and execution risks.

Yet while AI agents may expand Rubrik’s opportunity, investors should also be aware of the risk that newer products like Agent Cloud remain small and...

Rubrik's narrative projects $2.5 billion revenue and $302.9 million earnings by 2029. This requires 20.6% yearly revenue growth and a $591.5 million earnings increase from -$288.6 million today.

Uncover how Rubrik's forecasts yield a $95.50 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Compared with the baseline view, the most bullish analysts were already assuming about 24.1 percent annual revenue growth and US$329.8 million in earnings by 2029, so if Agent Identity accelerates or disappoints adoption around agent based AI, your stance on whether that upside or the risk of Agent Cloud not scaling justifies those expectations may shift meaningfully.

Explore 8 other fair value estimates on Rubrik - why the stock might be worth as much as 30% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Rubrik research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Rubrik research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rubrik's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Find 51 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 19 elite penny stocks that balance risk and reward.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.